Shareholders Back Reverse Split to Keep Fractyl Health on Nasdaq

summarizeSummary

Fractyl Health shareholders approved a reverse stock split (1-for-5 to 1-for-15) at a special meeting, giving the board authority to set the ratio and execute the split to regain Nasdaq compliance.

check_boxKey Events · Corporate Governance and Compliance · GUTS

• Reverse Stock Split Approved

  Shareholders voted 102,476,581 for, 9,319,450 against, and 191,821 abstentions to approve a reverse stock split at a ratio between 1-for-5 and 1-for-15, with the board authorized to set the exact ratio.

• Strong Quorum and Support

  111,987,852 shares were represented at the special meeting, representing 70.35% of the 159,179,848 shares outstanding as of the August 21, 2026 record date.

• Nasdaq Compliance Path

  The approval follows a formal delisting notice received from Nasdaq on September 10, 2026, after the company failed to regain the $1.00 minimum bid price requirement.

• Board Discretion on Ratio

  The board now has sole discretion to select the exact reverse split ratio within the approved 1-for-5 to 1-for-15 range and to determine the timing of the split.

auto_awesomeAnalysis · GUTS · Industrial Applications And Services

With overwhelming support, shareholders approved a reverse stock split at a ratio between 1-for-5 and 1-for-15, leaving the board to set the exact terms. This clears a key hurdle for lifting the stock price above Nasdaq's $1.00 minimum bid requirement, which became urgent after a formal delisting notice arrived on September 10. The vote removes uncertainty about whether the company could act, but the board still must choose and execute a ratio — and the split itself does not resolve the underlying going-concern financial challenges.